Home  >  News
  Tiziana Life Sciences initiates phase IIa clinical trial with milciclib in patients with Hepatocellular carcinoma,   July 24, 2017
  Theravance Biopharma, Mylan report positive results from phase 3 safety study of revefenacin in patients with COPD,   July 22, 2017
  RedHill Biopharma announces last patient enrollment in BEKINDA phase II study for IBS-D,   July 22, 2017
  Kitov Pharma reports positive results from pre-clinical study of NT-219 in combo with Keytruda,   July 21, 2017
  Humabs BioMed, University of California, announce publication of data for novel antibody-based assay to detect Zika virus infection,   July 19, 2017
  BrainStorm sign pact with Massachusetts General Hospital & CPMC to participate in phase 3 trial of NurOwn in ALS,   July 19, 2017
  Novartis announces positive results from phase III long-term extension study of Cosentyx in patients with plaque psoriasis,   July 17, 2017
  Amgen's phase 3 ASPIRE study of Kyprolis to treat relapsed multiple myeloma meets key secondary endpoint,   July 14, 2017
  Boehringer Ingelheim phase III study results confirm benefit of Praxbind as reversal agent for Pradaxa patients in emergency situations,   July 13, 2017
  Sanofi Genzyme announces positive results from phase 2 OLE study with fitusiran in patients with Hemophilia A and B,   July 12, 2017
  Arena Pharma announces positive results from phase 2 study of ralinepag to treat patients with pulmonary arterial hypertension,   July 12, 2017
  PDS inks clinical collaboration with Merck to evaluate Versamune PDS0101 & Keytruda combo for metastatic head and neck cancer,   July 11, 2017
  Ionis Pharma presents positive data from phase 3 NEURO-TTR study of inotersen in patients with FAP at PNS meeting,   July 11, 2017
  Prothena initiates phase 2 PASADENA study of PRX002/RG7935 in patients with early Parkinson's disease,   July 11, 2017
  Chugai presents global phase III study results of emicizumab in paediatric patients with haemophilia A at 26th ISTH meeting,   July 11, 2017
  GRAZAX asthma prevention trial reveals benefits of early treatment intervention in children,   July 10, 2017
  Anthera begins screening in Europe in phase 3 clinical study of sollpura for EPI due to cystic fibrosis,   July 08, 2017
  Inovio's NA-based monoclonal antibody platform achieves proof-of-principle validation,   July 08, 2017
  Cytovia reports additional trial results on efficacy of Ceplene in combo with low-dose IL-2 in patients with AML,   July 07, 2017
  BioNTech announces positive results from phase 1 trial of individualized cancer vaccine Ivac Mutanome,   July 07, 2017

Copyright © 2016 Saffron Media Pvt. Ltd |